Related Experiment Videos
Targeting kinases in asthma
1Celgene, 4550 Towne Centre Court, San Diego, CA 92121, USA. kblease@celgene.com
Expert Opinion on Investigational Drugs
|September 28, 2005
Summary
Kinase signaling pathways are crucial in asthma development. Targeting specific kinases with novel inhibitors offers a promising therapeutic strategy for treating this complex inflammatory disease.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Kinase signaling pathways regulate diverse cellular processes through phosphorylation.
- Aberrant kinase activity is implicated in the pathogenesis of immune and inflammatory diseases.
- Asthma involves complex immune, inflammatory, and airway remodeling events.
Purpose of the Study:
- To review the role of specific kinase families in asthma pathogenesis.
- To discuss the therapeutic potential of kinase inhibitors for asthma treatment.
Main Methods:
- Information gathered from transgenic and knockout systems.
- Analysis of small-molecule inhibitors targeting kinases.
- Review of antisense technology applications.
Main Results:
- Mitogen-activated kinases, tyrosine kinases, and ras human orthologue kinases are key players in asthma.
- These kinases contribute to immune dysregulation, inflammation, and airway remodeling in asthma.
- Preclinical studies support the role of kinase inhibition in mitigating asthma pathology.
Conclusions:
- Specific kinase pathways are critical targets for asthma intervention.
- Development of targeted kinase inhibitors holds significant therapeutic promise for asthma management.
- Further research into kinase inhibitors could lead to novel asthma treatments.